
上下游产品
[(2R,3S)-2-(2,5-二氟苯基)-5-羟基四氢-2H-吡喃-3-基]氨基甲酸叔丁酯 Tert-Butyl ((2R,3S)-2-(2,5-Difluorophenyl)-5-Hydroxytetrahydro-2H-Pyran-3-yl)Carbamate 1172623-99-2
Tert-Butyl [(2R,3S)-5-Methylene-2-(2,5-Difluorophenyl)-Tetrahydro-2H-Pyran-3-Yl]Carbamate 951127-31-4
Tert-Butyl N-[(2R,3S)-5-Hydroxy-5-(Hydroxymethyl)-2-(2,5-Difluorophenyl)Tetrahydro-2H-Pyran-3-Yl]Carbamate 951127-32-5
N-[(2R,3S)-2-(2,5-二氟苯基)-3,4-二氢-2H-吡喃-3-基]氨基甲酸叔丁酯 Tert-Butyl ((2R,3S)-2-(2,5-Difluorophenyl)-3,4-Dihydro-2H-Pyran-3-yl)Carbamate 1172623-98-1
Tert-Butyl [(1S,2S)-1-(2,5-Difluorophenyl)-1-Hydroxypent-4-Yn-2-Yl]Carbamate
Tert-Butyl ((1R,2S)-1-(2,5-Difluorophenyl)-1-Hydroxypent-4-Yn-2-yl)Carbamate
(2R,3S)-2-(2,5-Difluorophenyl)-5-Methylenetetrahydro-2H-Pyran-3-Amine 951127-30-3
Trans-5-Methylene-3-Nitro-2-(2,5-Difluorophenyl)-Tetrahydro-2H-Pyran
(2R,3S)-2-(2,5-Difluorophenyl)-5-Methylidene-3-Nitrotetrahydro-2H-Pyran 951127-29-0
[1-(2,5-二氟苯基)-1-氧代-4-戊炔-2-基]氨基甲酸叔丁酯 Tert-Butyl (1-(2,5-Difluorophenyl)-1-Oxopent-4-Yn-2-yl)Carbamate 1172623-96-9合成工艺路线路线简述
- 2169997-99-1 = 951127-25-6
反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Ethyl Acetate,Water; Overnight,Rt
标题:Preparation Of Chiral Intermediate Of Omarigliptin
参考文献:China]
1172623-99-2 = 951127-25-6
反应条件:1.1 Reagents: Dess-Martin Periodinane Solvents: Dichloromethane; 0 °C; 4 H,0 °C -> Rt; Rt -> 0 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water; 0 °C; 20 Min,0 °C
标题:Hydrate Of Pyran Derivative Or Its Salt,And Preparing Method And Application Thereof
参考文献:China]
1172623-99-2 = 951127-25-6
反应条件:1.1 Reagents: Dess-Martin Periodinane Solvents: Dichloromethane; 0 °C; 4 H,0 °C -> Rt; Rt -> 0 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water; 0 °C; 20 Min,0 °C
标题:Preparation Of Pyrroloimidazole Derivatives As Dipeptidyl Peptidase Iv (Dpp-Iv) Inhibitors
参考文献:World Intellectual Property Organization]
1172623-99-2 = 951127-25-6
反应条件:1.1 Reagents: Dess-Martin Periodinane Solvents: Dichloromethane; 0 °C; 0 °C -> Rt; 4 H,Rt; Rt -> 0 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water; 20 Min,0 °C
标题:Preparation Of Imidazole Derivatives As Dipeptidyl Peptidase Iv Inhibitors
参考文献:China]
= 951127-25-6
反应条件:1.1 Reagents: Zinc Chloride Solvents: Ethanol; 0 °C
标题:Application Of Asymmetric Addition Reaction In Synthesis Of Omarigliptin Intermediate
参考文献:China]
951127-31-4 = 951127-25-6
反应条件:1.1 Reagents: N-Methylmorpholine N-Oxide,Osmium Tetroxide1.2 Reagents: Sodium Periodate
标题:Novel Tetrahydropyran Analogs As Dipeptidyl Peptidase Iv Inhibitors: Profile Of Clinical Candidate (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-(4,6-Dihydropyrrolo[3,4-C]Pyrazol-5-(1H)-Yl)Tetrahydro-2H-Pyran-3-Amine (23)
作者:Biftu,Tesfaye; Qian,Xiaoxia; Chen,Ping; Feng,Dennis; Scapin,Giovanna; Et Al
参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2013 卷标:23(19) 页码:5361-5366]
951127-31-4 = 951127-25-6
反应条件:1.1 Reagents: Sodium Periodate,Ruthenium Trichloride Solvents: Acetonitrile,Dichloromethane,Water; 3 H,25 °C
标题:Preparation Of 2-Phenyl-Heterocyclyl-Tetrahydro-2H-Pyran-3-Amine Compounds For Use In The Treatment Of Diabetes And Its Associated Disorders
参考文献:India]
1172623-99-2 = 951127-25-6
反应条件:1.1 Reagents: Dess-Martin Periodinane Solvents: Dichloromethane; 0 °C; 0 °C -> Rt; 4 H,Rt; Rt -> 0 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water; 0 °C; 20 Min,0 °C
标题:Preparation Of 2-Phenyl-3-Amino-4-Fluorotetrahydropyran Derivatives Useful As Dpp-Iv Inhibitors For The Treatment Of Metabolic Disease
参考文献:China]
1172623-99-2 = 951127-25-6
反应条件:1.1 Reagents: Dess-Martin Periodinane Solvents: Dichloromethane; 0 °C; 4 H,0 °C -> Rt; Rt -> 0 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water; 0 °C; 20 Min,0 °C
标题:Amino Pyranoid Ring Derivative As Dpp-Iv Inhibitor And Its Preparation
参考文献:World Intellectual Property Organization]
1172623-99-2 = 951127-25-6
反应条件:1.1 Reagents: Dess-Martin Periodinane Solvents: Dichloromethane; 0 °C; 4 H,Rt; Rt -> 0 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water; 0 °C; 20 Min,0 °C
标题:Amino Six-Membered Ring Derivatives And Application
参考文献:China]
1172623-99-2 = 951127-25-6
反应条件:1.1 Reagents: Sodium Hypochlorite Solvents: Dichloromethane,Water; 3 H,Rt
标题:Method For Preparing Key Intermediate Of Alogliptin Using 2,5-Difluorobenzaldehyde
参考文献:China]
1172623-99-2 = 951127-25-6
反应条件:1.1 Reagents: Acetic Acid,Sodium Bromate Catalysts: Ruthenium Trichloride Solvents: Acetonitrile,Water; < 2 °C; 0 °C
标题:Evolution Of A Manufacturing Route To Omarigliptin,A Long-Acting Dpp-4 Inhibitor For The Treatment Of Type 2 Diabetes
作者:Chung,John Y. L.; Scott,Jeremy P.; Anderson,Camille; Bishop,Brian; Bremeyer,Nadine; Et Al
参考文献:Organic Process Research & Development 日期:2015 卷标:19(11) 页码:1760-1768]
= 951127-25-6
反应条件:1.1 Reagents: Acetic Acid,Sodium Bromate Catalysts: Ruthenium Trichloride Solvents: Acetonitrile,Water; 0 °C; 0 °C1.2 Solvents: Water; 5 H,0 °C; Overnight,0 °C
标题:Asymmetric Synthesis Of Highly Functionalized Tetrahydropyran Dpp-4 Inhibitor
作者:Xu,Feng; Zacuto,Michael J.; Kohmura,Yoshinori; Rosen,Jon; Gibb,Andrew; Et Al
参考文献:Organic Letters 日期:2014 卷标:16(20) 页码:5422-5425]
24424-99-5 + 2162942-94-9 = 951127-25-6
反应条件:1.1 Solvents: Dichloromethane; 0 °C; 0 °C -> Rt1.2 Reagents: Triphenylphosphine,Trichlorooxobis(Triphenylphosphine)Rhenium Solvents: Dichloromethane; Rt1.3 Reagents: Bismuth Trichloride,Bismuth Nitrate Solvents: Water; Rt
标题:Application Of Enzyme Catalysis Technology In Synthesis Of Intermediate Of Omarigliptin
参考文献:China
Boc-L-炔丙基甘氨酸置于n-甲基吗啉,Sodium Hydrogensulfate Monohydrate,水,异丙基氯化镁,氯甲酸乙酯,Aluminum Isopropoxide,Sodium Carbonate,异丙醇,Potassium Hydroxide体系中,用 四氢呋喃,甲醇,二氯甲烷 作为反应溶剂,化学反应 16.5H,反应生成 N-[(2R,3S)-2-(2,5-二氟苯基)四氢-5-氧代-2H-吡喃-3-基]氨基甲酸叔丁酯
参考文献:奥格列汀关键中间体合成的另一种可扩展方法
标题:奥格列汀关键中间体合成的另一种可扩展方法
摘要:描述了奥格列汀关键中间体合成的另一种可扩展方法.不对称合成依赖于最初的非对映选择性烷基化和随后的铝催化的底物控制的meerwein-ponndorf-verley还原.甲高度选择性5-外切挖iodocyclization随后,得到图11B中,然后进行开环cycloetherification,得到产物1 > 99:1个博士和> 99%ee的在31.2%的总收率在九个步骤.该合成策略已成功应用于多千克规模的生产.
DOI:10.1021/acs.Oprd.6B00295
海关参考信息
- 2902600000-乙苯
2905122000-异丙醇
2905143000-叔丁醇
2906210000-苄醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-9481680-B2
优先权日:2014-03-20
标题 :Process for the preparation of key intermediates of omarigliptin
发明人:DE LUCCHI OTTORINO; ROSSO ENRICO; ZARAMELLA SIMONE; TARTAGGIA STEFANO
权利人:F I S —FABBRICA ITALIANA SINTETICI S P A; F I S —FABBRICA ITALIANA SINTETICI S P A
摘要:An improved process for the preparation of a key intermediate for the synthesis of the active ingredient Omarigliptin is provided. The key intermediate is a compound having the following formula (I) n nwherein R 1 is propargyl or allyl group and P is an amine protecting group. The compound of formula (I) is prepared by converting a compound of formula (IV)n n nby an amination reaction to a compound of formula (III),n n nwhich is then protected to provide a compound of formula (II),n n nwhich is then alkylated to provide the compound of formula (I).
专利号:US-9527855-B2
优先权日:2011-06-29
标题:Process for preparing chiral dipeptidyl peptidase-IV inhibitors
发明人:ZACUTO MICHAEL J; DUNN ROBERT F; MOMENT AARON J; JANEY JACOB M; LIEBERMAN DAVID; SHEEN FAYE; BREMEYER NADINE; SCOTT JEREMY; KUETHE JEFFREY T; TAN LUSHI; CHEN QINGHAO
权利人:MERCK SHARP & DOHME; MERCK SHARP & DOHME
摘要:A process for the preparation of pyrazolopyrolidines of structural formula I: n nand W isn n nor P, wherein in P is an amine protecting group. These compounds are useful in the synthesis of dipeptidyl peptidase-IV inhibitors for the treatment of Type 2 diabetes. Also provided are useful intermediates obtained from the process.
专利号:US-7902376-B2
优先权日:2008-01-23
标 题 :Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates
发明人:XU FENG; KIM MARY M; KOHMURA YOSHINORI; SLADICKA TRICIA; ROSEN JONATHAN D; ZACUTO MICHAEL J
权利人:MERCK SHARP & DOHME; BANYU PHARMA CO LTD
摘要:A novel process is provided for the preparation of chiral trans-2,3-disubstituted 5-oxotetrahydropyrans of structural formula (I): n nwherein Ar is optionally substituted phenyl and P is a primary amine protecting group. These compounds are useful in the synthesis of dipeptidyl peptidase-IV inhibitors for the treatment of Type 2 diabetes. Also provided are useful intermediates obtained from the process.